MME
IDXX icon

Meag Munich Ergo’s Idexx Laboratories IDXX Stock Holding History

Meag Munich Ergo’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$3.25M Buy
6,051
+5,845
+2,837% +$2.8M 0.09% 112
2025
Q1 		$86.5K Hold
206
– – ﹤0.01% 184
2024
Q4 		$85K Hold
206
– – ﹤0.01% 197
2024
Q3 		$104K Hold
206
– – ﹤0.01% 189
2024
Q2 		$100K Sell
206
-1,181
-85% -$593K ﹤0.01% 171
2024
Q1 		$749K Sell
1,387
-937
-40% -$512K 0.03% 134
2023
Q4 		$1.29M Sell
2,324
-891
-28% -$418K 0.05% 124
2023
Q3 		$1.41M Buy
+3,215
New +$1.6M 0.06% 118
2023
Q2 		– Sell
-158
Closed -$79K – 191
2023
Q1 		$79K Sell
158
-1,210
-88% -$579K ﹤0.01% 176
2022
Q4 		$558K Hold
1,368
– – 0.03% 180
2022
Q3 		$446K Hold
1,368
– – 0.03% 180
2022
Q2 		$480K Sell
1,368
-987
-42% -$402K 0.03% 176
2022
Q1 		$1.3M Sell
2,355
-7,240
-75% -$3.81M 0.09% 124
2021
Q4 		$6.37M Sell
9,595
-1,062
-10% -$667K 0.45% 54
2021
Q3 		$6.63M Sell
10,657
-2,528
-19% -$1.7M 1.15% 23
2021
Q2 		$8.33M Buy
13,185
+4,577
+53% +$2.53M 0.8% 23
2021
Q1 		$4.21M Buy
8,608
+3,691
+75% +$1.85M 0.42% 62
2020
Q4 		$2.44M Sell
4,917
-1,067
-18% -$477K 0.56% 57
2020
Q3 		$2.35M Sell
5,984
-3
-0.1% -$1.11K 0.44% 59
2020
Q2 		$1.98M Sell
5,987
-551
-8% -$160K 0.37% 78
2020
Q1 		$1.58M Buy
6,538
+5,134
+366% +$1.34M 0.38% 78
2019
Q4 		$367K Sell
1,404
-6,386
-82% -$1.68M 0.04% 317
2019
Q3 		$2.11M Buy
7,790
+2,460
+46% +$685K 0.11% 204
2019
Q2 		$1.45M Buy
5,330
+2,124
+66% +$523K 0.11% 190
2019
Q1 		$707K Buy
+3,206
New +$662K 0.06% 316
2018
Q2 		– Sell
-12,556
Closed -$2.36M – 403
2018
Q1 		$2.36M Buy
12,556
+8,376
+200% +$1.55M 0.1% 255
2017
Q4 		$668K Sell
4,180
-18,536
-82% -$2.92M 0.03% 410
2017
Q3 		$3.52M Sell
22,716
-11,953
-34% -$1.89M 0.14% 159
2017
Q2 		$5.55M Buy
+34,669
New +$5.63M 0.25% 135

Other funds holding IDXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Polen Capital Management
Polen Capital Management Boca Raton, Florida $14.5B AUM 5.7% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Meag Munich Ergo's IDXX Position: Q2 2025 in Review

Meag Munich Ergo increased its Idexx Laboratories (IDXX) stake by 2,837% in Q2 2025, buying an estimated $2.8M and bringing the position to 6,051 shares worth $3.25M. The position accounts for 0.09% of the portfolio, ranked #112.

Meag Munich Ergo first reported a position in IDXX in Q2 2017 and has held it in 29 quarters since. The position peaked at $8.33M in Q2 2021. 1,234 funds tracked by Wall St. Rank hold IDXX as of Q2 2025.

  • Meag Munich Ergo held 6,051 shares of Idexx Laboratories worth $3.25M as of Q2 2025.
  • Meag Munich Ergo bought 5,845 Idexx Laboratories shares in Q2 2025, an estimated $2.8M.
  • Idexx Laboratories made up 0.09% of Meag Munich Ergo's portfolio in Q2 2025, its #112 holding.
  • Meag Munich Ergo first reported a position in Idexx Laboratories in Q2 2017 and has held it in 29 quarters since.
  • Meag Munich Ergo's Idexx Laboratories position peaked at $8.33M in Q2 2021.
  • 1,234 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2025.

Based on Meag Munich Ergo's 13F filing for Q2 2025, filed 16 Jul 2025.